Image-guided ablation in the thorax

doi:10.1017/CBO9781107338555.024

24 - Image-guided ablation in the thorax

from Section VII - Organ-specific cancers – chest

Published online by Cambridge University Press: 05 September 2016

Erica S. Alexander and

Damian E. Dupuy

Edited by

Jean-Francois H. Geschwind and

Michael C. Soulen

Show author details

Erica S. Alexander: Affiliation:
Hospital of the University of Pennsylvania
Damian E. Dupuy: Affiliation:
Alpert Medical School of Brown University
Jean-Francois H. Geschwind: Affiliation:
Yale University School of Medicine, Connecticut
Michael C. Soulen: Affiliation:
Department of Radiology, University of Pennsylvania Hospital, Philadelphia

Book contents

Get access

Summary

Surgical resection remains the reference standard for the treatment of early-stage lung cancer and isolated pulmonary metastases in select patients. Although surgery offers patients the best chance of disease-free survival, only about a third of patients with non-small cell lung cancer (NSCLC) are considered candidates for surgical resection. Historically, these patients have been treated with chemotherapy or external-beam therapy; however, these modalities provide only modest improvements in overall survival. Over the past decade, several new minimally invasive therapies, such as thermal ablation, stereotactic body radiotherapy, and targeted receptor inhibitors, have emerged as promising treatment alternatives for non-operative candidates.

Thermal ablation is an exciting and cost-effective therapy that offers patients an effective and safe treatment to palliate and, in some cases, cure both primary and metastatic thoracic malignancies. The benefits of thermal ablation include that it can be repeated, used in previously irradiated fields, and used in conjunction with pharmacologic treatments, chemotherapy, or radiotherapy.

The goal of this chapter is to discuss and review the technologies and techniques available for tumor ablation of thoracic malignancies, including the basic physics of ablation, procedure technique, imaging follow-up, comparisons between therapies, and applications and outcomes for ablation therapy in the thorax.

Physics of ablation therapy

Image-guided tumor ablation utilizes thermal or electrical energy to create controlled destruction of cells and tissues. The three mainstays in thermal ablation therapy, radiofrequency ablation (RFA), microwave ablation (MWA), and cryoablation (CA), are discussed in this chapter. Additionally, irreversible electroporation (IRE), the newest ablation modality, is reviewed in this piece.

Radiofrequency ablation

In RFA, an alternating current about the frequency of radio waves (460–480 kHz) is created between an electrode and grounding pads placed on the patient. The insulated electrode has a conducting tip that creates ion agitation in adjacent tissue, as electrons move toward the reference electrodes (grounding pads). This friction is converted to heat, leading to thermal injury and cell death in a controlled manner. The goal of RFA is to achieve temperatures between 60°C and 100°C, which allow for near-instantaneous protein coagulation, damage to cytosolic and mitochondrial enzymes, and damage to DNA–histone complexes.

Information

Type: Chapter
Information: Interventional Oncology
Principles and Practice of Image-Guided Cancer Therapy
, pp. 223 - 242

DOI: https://doi.org/10.1017/CBO9781107338555.024 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2016

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

1. Ruckdeschel, JC, Schwarz, AG, Bepler, G, et al. Cancer of the lung – NSCLC and SCLC. In Aneloff, MD, Armitage, JO, Niederhuber, JE, eds. Abeloff's Clinical Oncology. 4th edn. Philadelphia, PA: Elsevier, 2008; pp. 1649–1743.

2. Gazelle, GS, Goldberg, SN, Solbiati, L, et al. Tumor ablation with radiofrequency energy. Radiology 2000; 217: 633–646.Google Scholar

3. Servas, NT, Kuwayama, A. Pathological characteristics of experimental thermal lesions. Comparison of induction heating and radiofrequency electrocoagulation. J Neurosurg 1972; 37: 418–422.Google Scholar

4. Nikfarjam, M, Muralidharan, V, Christophi, C. Mechanisms of focal heat destruction of liver tumors. J Surg Res 2005; 127: 208–223.Google Scholar

5. Ponder, E. The coefficient of thermal conductivity of blood and various tissues. J Gen Physiol 1962; 45: 545–451.Google Scholar

6. Dupuy, DE, Goldberg, SN. Image-guided radiofrequency tumor ablation: challenges and opportunities: Part II. J Vasc Interv Radiol 2001; 12 (10): 1135–1148.Google Scholar

7. Solazzo, SA, Liu, Z, Lobo, SM, et al. Radiofrequency ablation: importance of background tissue electrical conductivity – an agar phantom and computer modeling study. Radiology 2005; 236: 495–502.Google Scholar

8. Dupuy, DE, Mayo-Smith, WW, Abbott, GF, DiPetrillo, T. Clinical applications of radio-frequency tumor ablation in the thorax. Radiographics 2002; 22(Spec No): S259–S269.Google Scholar

9. Simon, CJ, Dupuy, DE, Mayo-Smith, WW. Microwave ablation: principles and applications. Radiographics 2005; 25(Suppl 1): S69–S83.Google Scholar

10. Brace, CL, Hinshaw, JL, Laeseke, PF, Sampson, LA, Lee, FT Jr. Pulmonary thermal ablation: comparison of radiofrequency and microwave devices by using gross pathologic and CT findings in a swine model. Radiology 2009; 251 (3): 705–711.Google Scholar

11. Dupuy, DE. Microwave ablation compared with radiofrequency ablation in lung tissue – is microwave not just for popcorn any more? Radiology 2009; 251 (3): 617–618.Google Scholar

12. Skinner, MG, Iizuka, MN, Kolios, MC, Sherar, MD. A theoretical comparison of energy sources – microwave, ultrasound, laser – for interstitial thermal therapy. Phys Med Biol 1998; 43: 3535–3547.Google Scholar

13. Wright, AS, Lee, FT Jr, Mahvi, DM. Hepatic microwave ablation with multiple antennae results in synergistically larger zones of coagulation necrosis. Ann Surg Oncol 2003; 10: 275–283.Google Scholar

14. Meredith, K, Lee, F, Henry, MB, Warner, T, Mahvi, D. Microwave ablation of hepatic tumors using dual-loop probes: results of a phase I clinical trial. J Gastrointest Surg 2005; 9: 1354–1360.Google Scholar

15. Yu, NC, Lu, DS, Raman, SS, et al. Hepatocellular carcinoma: microwave ablation with multiple straight and loop antenna clusters – pilot comparison with pathologic findings. Radiology 2006; 239 (1): 269–275.Google Scholar

16. Hinshaw, JL, Littrup, PJ, Durick, N, et al. Optimizing the protocol for pulmonary cryoablation: a comparison of a dual- and triple-freeze protocol. Cardiovasc Intervent Radiol 2010; 33 (6): 1180–1185.Google Scholar

17. Rubinsky, B, Onik, G, Mikus, P. Irreversible electroporation: a new ablation modality – clinical implications. Technol Cancer Res Treat 2007; 6 (1): 37–48.Google Scholar

18. Davalos, RV, Mir, IL, Rubinsky, B. Tissue ablation with irreversible electroporation. Ann Biomed Eng 2005; 33 (2): 223–231.Google Scholar

19. Maor, E, Ivorra, A, Leor, J, et al. The effect of irreversible electroporation on blood vessels. Technol Cancer Res Treat 2007; 6 (4): 307–312.Google Scholar

20. Rempp, H, Boss, A, Helmberger, T, Pereira, P. The current role of minimally invasive therapies in the management of liver tumors. Abdom Imaging 2011; 36 (6): 635–647.Google Scholar

21. Alexander, ES, Healey, TT, Martin, DW, Dupuy, DE. Use of endobronchial valves for the treatment of bronchopleural fistulas after thermal ablation of lung neoplasms. J Vasc Interv Radiol 2012; 23 (9): 1236–1240.Google Scholar

22. Skonieczki, BD, Wells, C, Wasser, EJ, Dupuy, DE. Radiofrequency and microwave tumor ablation in patients with implanted cardiac devices: is it safe? Eur J Radiol 2011; 79 (3): 343–346.Google Scholar

23. VanSonnenberg, E, Shankar, S, Morrison, PR, et al. Radiofrequency ablation of thoracic lesions: part 2, initial clinical experience – technical and multidisciplinary considerations in 30 patients. AJR Am J Roentgenol 2005; 184 (2): 381–1013.Google Scholar

24. Solomon, SB, Thornton, RH, Dupuy, DE, Downey, RJ. Protection of the mediastinum and chest wall with an artificial pneumothorax during lung ablations. J Vasc Interv Radiol 2008; 19 (4): 610–615.Google Scholar

25. Hinshaw, JL, Lee, FT Jr, Laeseke, PF, Sampson, LA, Brace, C. Temperature isotherms during pulmonary cryoablation and their correlation with the zone of ablation. J Vasc Interv Radiol 2010; 21 (9): 1424–1428.Google Scholar

26. Usman, M, Moore, W, Talati, R, Watkins, K, Bilfinger, TV. Irreversible electroporation of lung neoplasm: a case series. Med Sci Monit 2012; 18 (6): CS43–CS47.Google Scholar

27. Thomson, KR, Cheung, W, Ellis, SJ, et al. Investigation of the safety of irreversible electroporation in humans. J Vasc Interv Radiol 2011; 22 (5): 611–621.Google Scholar

28. Dupuy, DE, Aswad, B, Ng, T. Irreversible electroporation in a swine lung model. Cardiovasc Intervent Radiol 2011; 34 (2): 391–395.Google Scholar

29. Anderson, EM, Lees, WR, Gillams, AR. Early indicators of treatment success after percutaneous radiofrequency of pulmonary tumors. Cardiovasc Intervent Radiol 2009; 32: 478–483.Google Scholar

30. de Baere, T, Palussiere, J, Auperin, A, et al. Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation. Radiology 2006; 240: 587–596.Google Scholar

31. Lee, JM, Jin, GY, Goldberg, SN, et al. Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report. Radiology 2004; 230 (1): 125–134.Google Scholar

32. Bojarski, JD, Dupuy, DE, Mayo-Smith, WW. CT imaging findings of pulmonary neoplasms after treatment with radiofrequency ablation: results in 32 tumors. AJR Am J Roentgenol 2005; 185 (2): 466–471.Google Scholar

33. Steinke, K, King, J, Glenn, D, Morris, DL. Radiologic appearance and complications of percutaneous computer tomography-guided radiofrequency-ablated pulmonary metastases from colorectal carcinoma. J Comput Assist Tomogr 2003; 27 (5): 750–757.Google Scholar

34. Miao, Y, Ni, Y, Bosmans, H, et al. Radiofrequency ablation for eradication of pulmonary tumor in rabbits. J Surg Res 2001; 99 (2): 265–271.Google Scholar

35. Gadaleta, C, Mattioli, V, Colucci, G, et al. Radiofrequency ablation of 40 lung neoplasms: preliminary results. AJR Am J Roentgenol 2004; 183 (2): 361–368.Google Scholar

36. Goldberg, S Nahum, Dupuy, DE. Image-guided radiofrequency tumor ablation: challenges and opportunities – part I. J Vasc Interv Radiol 2001; 12 (9): 1021–1032.Google Scholar

37. Jin, GY, Lee, JM, Lee, YC, Han, YM, Lim, YS. Primary and secondary lung malignancies treated with percutaneous radiofrequency ablation: evaluation with follow-up helical CT. AJR Am J Roentgenol 2004; 183 (4): 1013–1020.Google Scholar

38. Bonichon, F, Palussiere, J, Godbert, Y, et al. Diagnostic accuracy of 18F-FDG PET/CT for assessing response to radiofrequency ablation treatment in lung metastases: a multicentre prospective study. Eur J Nucl Med Mol Imaging 2013; 40 (12): 1817–1827.Google Scholar

39. Yoo, DC, Dupuy, DE, Hillman, SL, et al. Radiofrequency ablation of medically inoperable stage IA non-small cell lung cancer: are early posttreatment PET findings predictive of treatment outcome? AJR Am J Roentgenol 2011; 197 (2): 334–340.Google Scholar

40. Deandreis, D, Leboulleux, S, Dromain, C, et al. Role of FDG PET/CT and chest CT in the follow-up of lung lesions treated with radiofrequency ablation. Radiology 2011; 258 (1): 270–276.Google Scholar

41. Wolf, FJ, Grand, DJ, Machan, JT, et al. Microwave ablation of lung malignancies: effectiveness, CT findings, and safety in 50 patients. Radiology 2008; 247 (3): 871–879.Google Scholar

42. Ito, N, Nakatsuka, S, Inoue, M, et al. Computed tomographic appearance of lung tumors treated with percutaneous cryoablation. J Vasc Interv Radiol 2012; 23 (8): 1043–1052.Google Scholar

43. Kawamura, M, Izuma, Y, Tsukada, N, et al. Percutaneous cryoablation of small pulmonary malignant tumors under computer tomographic guidance with local anesthesia for nonsurgical candidates. J Thorac Cardiovasc Surg 2006; 131 (5): 1007–1013.Google Scholar

44. Ahrar, K, Stafford, RJ, Tinkey, PT, et al. Evaluation of cerebral microemboli during radiofrequency ablation of lung tumors in a canine model. J Vasc Interv Radiol 2006; 17: S63.Google Scholar

45. Maiwand, MO. The role of cryosurgery in palliation of tracheobronchial carcinoma. Eur J Cardiothorac Surg 1999; 15 (6): 764–768.Google Scholar

46. Maiwand, MO, Homasson, JP. Cryotherapy for tracheobronchial disorders. Clin Chest Med 1995; 16 (3): 427–443.Google Scholar

47. Crabtree, T, Puri, V, Timmerman, R, et al. Treatment of stage I lung cancer in high-risk and inoperable patients: comparison of prospective clinical trials using stereotactic body radiotherapy (RTOG 0236), sublobar resection (ACOSOG Z4032), and radiofrequency ablation (ACOSOG Z4033). J Thorac Cardiovasc Surg 2013; 145 (3): 692–699.Google Scholar

48. Dupuy, DE, Zagoria, RJ, Akerley, W, et al. Percutaneous radiofrequency ablation of malignancies in the lung. AJR Am J Roentgenol 2000; 174 (1): 57–59.Google Scholar

49. Garetto, I, Busso, M, Sardo, D, et al. Radiofrequency ablation of thoracic tumours: lessons learned with ablation of 100 lesions. Radiol Med 2014; 119 (1): 33–40.Google Scholar

50. Caravajal, JM Galbis, Fayos, J Jornet, Torres, M Cuenca, et al. Study of survival in patients with malignant lung lesions treated with radiofrequency. Clin Transl Oncol 2013; 15 (10): 830–835.Google Scholar

51. Ambrogi, MC, Fanucchi, O, Cioni, R, et al. Long-term results of radiofrequency ablation treatment of stage 1 non-small cell lung cancer: a prospective intention-to-treat study. J Thorac Oncol 2011; 6 (12): 2044–2051.Google Scholar

52. Kashima, M, Yamakado, K, Takaki, H, et al. Complications after 1000 lung radiofrequency ablations in 420 patients: a single center's experience. AJR Am J Roentgenol 2011; 197 (4): W576–W580.Google Scholar

53. Palussiere, J, Marcet, B, Descat, E, et al. Lung tumors treated with percutaneous radiofrequency ablation: computer tomography imaging follow-up. Cardiovasc Intervent Radiol 2011; 34 (5): 989–997.Google Scholar

54. Okuma, T, Matsuoka, T, Yamamoto, A, et al. Determinants of local progression after computer tomography-guided percutaneous radiofrequency ablation for unresectable lung tumors: 9 year experience in a single institution. Cardiovasc Intevent Radiol 2010; 33: 787–793.Google Scholar

55. Singnurkar, A, Solomon, SM, Gonen, M, Larson, SM, Schoder, H. 18F-FDG PET/CT for the prediction and detection of local recurrence after radiofrequency ablation of malignant lung lesions. J Nucl Med 2010; 51 (12): 1833–1840.Google Scholar

56. Chua, TC, Sarkir, A, Saxena, A, et al. Long-term outcome of image-guided percutaneous radiofrequency ablation of lung metastases: an open-labeled prospective trial of 148 patients. Ann Oncol 2010; 21 (10): 2017–2022.Google Scholar

57. Chua, TC, Thornbury, K, Saxena, A, et al. Radiofrequency ablation as an adjunct to systemic chemotherapy for colorectal pulmonary metastases. Cancer 2010; 116 (9): 2106–2114.Google Scholar

58. Pennathur, A, Abbas, G, Gooding, WE, et al. Image-guided radiofrequency ablation of lung neoplasm in 100 consecutive patients by a thoracic surgical service. Ann Thorac Surg 2009; 88 (5): 1601–1606.Google Scholar

59. Yamakado, K, Inoue, Y, Takao, M, et al. Long-term results of radiofrequency ablation in colorectal lung metastases: single center experience. Oncol Rep 2009; 22 (4):885–891.Google Scholar

60. Nour-Eldin, NE, Naguib, NN, Saeed, AS, et al. Risk factors involved in the development of pneumothorax during radiofrequency ablation of lung neoplasms. AJR Am J Roentgenol 2009; 193 (1): W43–W48.Google Scholar

61. Yoshimatsu, R, Yamagami, T, Terayama, K, et al. Delayed and recurrent pneumothorax after radiofrequency ablation of lung tumors. Chest 2009; 135 (4):1002–1009.Google Scholar

62. Zhu, JC, Yan, TD, Glenn, D, Morris, DL. Radiofrequency ablation of lung tumors: feasibility and safety. Ann Thorac Surg 2009; 87 (4): 1023–1028.Google Scholar

63. Lencioni, R, Crocetti, L, Cioni, R. Response to radiofrequency ablation of pulmonary tumors: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol 2008; 9 (7):621–628.Google Scholar

64. Nomura, M, Yamakado, K, Nomoto, Y, et al. Complications after lung radiofrequency ablation: risk factors for lung inflammation. Br J Radiol 2008; 81 (963): 244–249.Google Scholar

65. Sano, Y, Kanazawa, S, Gibara, H, et al. Feasibility of percutaneous radiofrequency ablation for intrathoracic malignancies: a large single-center experience. Cancer 2007; 109 (7): 1397–1405.Google Scholar

66. Simon, CJ, Dupuy, DE, DiPetrillo, TA, et al. Pulmonary radiofrequency ablation: Long-term safety and efficacy in 153 patients. Radiology 2007; 243 (1): 268–275.Google Scholar

67. Hiraki, T, Sakurai, J, Tsuda, T, et al. Risk factors for local progression after percutaneous radiofrequency ablation of lung tumors: evaluation based on a preliminary review of 342 tumors. Cancer 2006; 107 (12): 2873–2880.Google Scholar

68. Yan, TD, King, J, Sjarif, A, Glenn, D, et al. Learning curve for percutaneous radiofrequency ablation of pulmonary metastases from colorectal carcinoma: a prospective study of 70 consecutive cases. Ann Surg Oncol 2006; 13 (12): 1588–1595.Google Scholar

69. Gadaleta, C, Catino, A, Mattiolo, V. Radiofrequency thermal ablation in the treatment of lung malignancies. In Vivo 2006; 20 (6A): 765–767.Google Scholar

70. Yan, T, King, J, Sjarif, A, et al. Percutaneous radiofrequency of pulmonary metastases from colorectal carcinoma: prognostic determinants for survival. Ann Surg Oncol 2006; 13 (11): 1529–1537.Google Scholar

71. Hiraki, T, Tajiri, N, Mimura, H, et al. Pneumothorax, pleural effusion, and chest tube placement after radiofrequency ablation of lung tumors: incidence and risk factors. Radiology 2006; 241 (1): 275–283.Google Scholar

72. Ambrogi, MC, Lucchi, M, Dini, P, et al. Percutaneous radiofrequency of lung tumors: results in the midterm. Eur J Cardiothorac Surg 2006; 30 (1): 177–183.Google Scholar

73. Kang, S, Luo, R, Liao, W, et al. Single group study to evaluate the feasibility and complications of RFA and usefulness of post-treatment positron emission tomography in lung tumors. World J Surg Oncol 2004; 2: 30.Google Scholar

74. Vogl, TJ, Worst, TS, Naguib, NN, et al. Factors influencing local tumor control in patients with neoplastic pulmonary nodules treated with microwave ablation: a risk-factor analysis. AJR Am J Roentgenol 2013; 200 (3): 665–672.Google Scholar

75. Belfiore, G, Ronza, F, Belfiore, MP, et al. Patient's survival in lung malignancies treated by microwave ablation: our experience on 56 patients. Eur J Radiol 2013; 82 (1): 177–181.Google Scholar

76. Lu, Q, Cao, W, Huang, L, et al. CT-guided percutaneous microwave ablation of pulmonary malignancies: results in 69 cases. Wolrd J Surg Oncol 2012; 7 (10): 80.Google Scholar

77. Yashiro, H, Nakatsuka, S, Inoue, M, et al. Factors affecting local progression after percutaneous cryoablation of lung tumors. J Vasc Interv Radiol 2013; 24 (6): 813–821.Google Scholar

78. Wang, H, Littrup, PJ, Duan, Y, et al. Thoracic masses treated with percutaneous cryotherapy: initial experience with more than 200 procedures. Radiology 2005; 235 (1): 289–298.Google Scholar

79. Alexander, ES, Hankins, CA, Machan, JT, Healey, TT, Dupuy, DE. Rib fractures after percutaneous radiofrequency and microwave ablation of lung tumors: incidence and relevance. Radiology 2013; 266 (3): 971–978.Google Scholar

80. Nour-Eldin, NE, Naguib, NN, Tawfik, AM, et al. Outcomes of an algorithmic approach to management of pneumothorax complicating thermal ablation of pulmonary neoplasms. J Vasc Interv Radiol 2011; 22 (9): 1279–1286.Google Scholar

81. Grieco, CA, Simon, CJ, Mayo-Smith, WW, et al. Percutaneous thermoablation as a palliative treatment for chest wall masses. J Vasc Interv Radiol 2006; 17: S61.Google Scholar

82. Yasui, K, Kanazawa, S, Sano, Y, et al. Thoracic tumors treated with CT-guided radiofrequency ablation: initial experience. Radiology 2004; 231 (3): 850–857.Google Scholar

83. Belfiore, G, Moggio, G, Tedeschi, E, et al. CT-guided radiofrequency ablation: a potential complementary therapy for patients with unresectable primary lung cancer – a preliminary report of 33 patients. AJR Am J Roentgenol 2004; 183 (4): 1003–1011.Google Scholar

84. Therasse, P, Arbuck, SG, Eisenhauer, EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92 (3): 205–216.Google Scholar

85. Yu, HA, Sima, CS, Huang, J. Local therapy with continued EGFR tyrosine kinase inhibitor therapy as a treatment strategy in EGFR mutant advanced lung cancers that have developed acquired resistance to EDGFR tyrosine kinase inhibitors. J Thorac Oncol 2013; 8 (3): 346–351.Google Scholar

86. American Cancer Society. Cancer Facts and Figures 2016. Atlanta, GA: American Cancer Society; 2016.

87. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. The International Registry of Lung Metastases. J Thorac Cardiovasc Surg 1997; 113 (1): 37–49.

88. Kvale, PA, Simoff, M, Prakash, UB. Lung cancer. Palliative care. Chest 2003; 123(1 Suppl): 284S–311S.Google Scholar

89. Watson, PN, Evans, RJ. Intractable pain with lung cancer. Pain 1987; 29 (2): 163–173.Google Scholar

90. Kishi, K, Nakamura, H, Sudo, A, et al. Tumor debulking by radiofrequency ablation in hypertrophic pulmonary osteoarthropathy associated with pulmonary carcinoma. Lung Cancer 2002; 38 (3): 317–320.Google Scholar

91. Patti, JW, Neeman, Z, Wood, BJ. Radiofrequency ablation for cancer-associated pain. J Pain 2002; 3 (6): 471–473.Google Scholar

92. Posteraro, AF, Dupuy, DE, Mayo-Smith, WW. Radiofrequency ablation of bony metastatic disease. Clin Radiol 2004; 59 (9): 803–811.Google Scholar

93. Simon, CJ, Dupuy, DE. Image-guided ablative techniques in pelvic malignancies: radiofrequency ablation, cryoablation, microwave ablation. Surg Oncol Clin North Am 2005; 14 (2): 419–431.Google Scholar

94. Simon, CJ, Dupuy, DE. Percutaneous minimally invasive therapies in the treatment of bone tumors: thermal ablation. Semin Musculoskelet Radiol 2006; 10 (2): 137–144.Google Scholar

95. Grieco, CA, Simon, CJ, Mayo-Smith, WW, et al. Percutaneous thermoablation as a palliative treatment for chest wall masses. Am J Clin Oncol 2007; 30 (4): 361–367.Google Scholar

96. Callstrom, MR, Charboneau, JW. Image-guided palliation of painful metastases using percutaneous ablation. Tech Vasc Interv Radiol 2007; 10: 120–131.Google Scholar

97. Dupuy, DE, Hong, R, Oliver, B, Goldberg, SN. Radiofrequency ablation of spinal tumors: temperature distribution in the spinal canal. AJR Am J Roentgenol 2000; 175: 1263–1266.Google Scholar

Accessibility standard: Unknown

Why this information is here

This section outlines the accessibility features of this content - including support for screen readers, full keyboard navigation and high-contrast display options. This may not be relevant for you.

Accessibility Information

Accessibility compliance for the PDF of this chapter is currently unknown and may be updated in the future.